IGFBP7 and Sepsis: Previous studies have reported that [TIMP-2]•[IGFBP7] (the product of TIMP-2 and IGFBP7) has shown significant predictive ability for the progression of AKI (stages 2–3) within 12 h of sample collection in patients with various diseases, including sepsis [11].